Clinical Trial Update: Pediatric Patients Aged 4 to 11 Years With APDS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a therapy for Activated PI3K-delta syndrome in pediatric patients aged 4 to 11 is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Activated Pi3k-delta Syndrome

Snippet

Sponsor: Pharming Technologies B.V. | Conditions: APDS | Phase 3 | Status: ACTIVE_NOT_RECRUITING